Annovera Ring and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Annovera Ring and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / segesterone
Brand name: Annovera
Synonyms: Ethinyl estradiol and segesterone (vaginal ring), Segesterone Acetate and Ethinyl Estradiol
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Annovera Ring-Insulin glargine, recombinant Subcutaneous
- Annovera Ring-Insulin glulisine
- Annovera Ring-Insulin Glulisine (Cartridges and Pens)
- Annovera Ring-Insulin Glulisine (Vials)
- Annovera Ring-Insulin glulisine Subcutaneous
- Annovera Ring-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Annovera vaginal ring
- Insulin glargine and lixisenatide Subcutaneous-Anodyne LPT
- Insulin glargine and lixisenatide Subcutaneous-AnodyneRx
- Insulin glargine and lixisenatide Subcutaneous-Anolor 300 Oral
- Insulin glargine and lixisenatide Subcutaneous-Anoro Ellipta
- Insulin glargine and lixisenatide Subcutaneous-Ansaid